Search results
Results from the WOW.Com Content Network
No. 4: Eli Lilly, 3.5% dividend yield Eli Lilly's 3.5% dividend ranks fourth in big pharma, and the company's dividend history is appealing -- until you reach 2009. For the first decade of the ...
Let's see which companies in the pharmaceutical industry offer the most promising. Dividend payers deserve a berth in any long-term stock portfolio. But seemingly attractive dividend yields are ...
With a five-year dividend growth rate of 7.57%, Bristol-Myers Squibb stands among the pharmaceutical industry's leaders in dividend growth. Looking ahead, the company appears well positioned to ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
Valeant Pharmaceuticals: Allergan, Inc: 45 58 Valeant Pharmaceuticals and activist investor Bill Ackman offered to buy Botox maker Allergan, proposing a cash-and-stock deal worth about $152.89. [31] 20 2014 Monsanto Company Inc. Syngenta AG: 40 51 Monsanto weighed $40 billion unsolicited bid for Swiss rival, Syngenta aiming to avoid US ...
The first ultra-high-yield dividend stock that makes for a no-brainer buy in the upcoming year is pharmaceutical juggernaut Pfizer (NYSE: PFE). Though Pfizer has been weighed down by shrinking ...